Cytiva, the former GE Healthcare Life Sciences, based in Marlborough, has entered an agreement with the pharmaceutical company Lakes BioScience, based in the United Kingdom, to help the European company optimize its manufacturing processes, Lakes BioScience announced Tuesday.
UMass Memorial Medical Center in Worcester has seen an increase in COVID-positive patients from 35 to 54 cases in less than one week, forcing the hospital to go on an elevated alert status, according to a Tuesday press release.
The homogeneity among news editorship in Central Massachusetts is not unique to the region, but it does bring with it inherent questions about who decides what stories are newsworthy, and who decides how they are told.
Biopharmaceutical company AbbVie will pay Marlborough beauty equipment company BTL Aesthetics, as part of a settlement over alleged patent infringement, according to a Tuesday press release.
Marlborough company Sunovion Pharmaceuticals announced on Thursday it granted exclusive commercial license rights in Europe to Portugese company Bial for Sunovion's KYNMOBI, an under-the-tongue drug treating OFF episodes in patients with Parkinson’s disease.
ExaGrid, a Marlborough disk-based backup hardware company, announced Thursday a strategic partnership with German service provider and distributor TIM AG.
Marlborough medical device manufacturer Boston Scientific Corp. acquired Lumenis, an Israel-based surgical company specializing in urological lasers, in a $1.1-billion deal announced on Wednesday.
Hologic, a Marlborough-based medical technology company, announced Monday that Anthem Blue Cross Blue Shield will cover the company’s Acessa procedure, which treats uterine fibroids, according to a press release from Hologic.
Realty company Wheelock Street Capital LLC, with headquarters in Boston and Greenwich, Conn., purchased a 43,000-square-foot office building in Marlborough for $6.9 million, according to the Southern Middlesex Registry of Deeds.Â